Cholecystokinin inhibits myotube fusion and may contribute to sarcopenia: Evidence from clinical and C2C12 myoblast studies.

J Chin Med Assoc · 2026 · PMC12900186 · PMID 41430742

Europe PMC DOI

hedged sentence

0.3430

closest p · 6.9× alpha

0.3430

boldest claim

The sentences

did not reach statistical significancep = 0.343not close (p > 0.1)

In model 1, which included all candidate variables, lower BMI was significantly associated with sarcopenia (OR: 0.820, 95% CI, 0.731-0.920, p < 0.001), while CCK levels did not reach statistical significance (OR: 1.000, 95% CI, 0.999-1.001, p = 0.343).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.